TB-500: Thymosin Beta-4 Fragment

TB-500 is a synthetic version of the active region of Thymosin Beta-4, a naturally occurring 43-amino-acid peptide present in nearly all human tissues. Thymosin Beta-4 plays a central role in tissue repair by promoting cell migration to sites of injury, regulating actin (a protein critical for cell structure and movement), and reducing inflammation. TB-500 specifically enhances the migration of keratinocytes and endothelial cells, which are essential for wound healing, blood vessel repair, and tissue remodeling.

The typical dosing protocol for TB-500 follows a loading phase followed by a maintenance phase. Loading doses of 5-10mg per week (often split into 2-3 injections) are administered for the first 4-6 weeks, followed by maintenance dosing of 2-5mg every 1-2 weeks. Unlike BPC-157, TB-500 has a systemic distribution pattern, meaning it does not need to be injected locally near an injury site. Subcutaneous injection anywhere on the body will distribute the peptide systemically. This makes it particularly useful for individuals with multiple injury sites or systemic inflammatory conditions.

The BPC-157 and TB-500 combination is considered the gold standard healing stack in the peptide community. These two compounds work through complementary mechanisms: BPC-157 promotes angiogenesis and growth factor receptor upregulation while TB-500 enhances cell migration and tissue remodeling. When used together, they address both the blood supply component (BPC-157) and the cellular repair component (TB-500) of the healing process. Clinical practitioners report that this combination produces significantly faster recovery from injuries, surgeries, and chronic inflammatory conditions than either peptide alone.